Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
No To Hattatsu ; 39(4): 300-3, 2007 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-17633089

RESUMO

A 7-year-old girl was diagnosed with generalized myasthenia gravis and became steroid-dependent. Dose of prednisolone could not be reduced to < 2 mg/kg/day on alternate days, despite adverse effects. Thymectomy was avoided. Oral tacrolimus was initiated at 1.0 - 1.3 mg/kg/day. Ptosis and weakness of the lingual and pharyngeal muscles began to ameliorate 2 weeks later, and disappeared within 2 months. Serum titer of anti-acetylcholine receptor antibody also declined. During the subsequent two years, remission was maintained although prednisolone was reduced to half the original dose. No adverse effects of tacrolimus were noted. This case suggests the usefulness of tacrolimus in the treatment of childhood myasthenia gravis.


Assuntos
Imunossupressores/uso terapêutico , Miastenia Gravis/tratamento farmacológico , Tacrolimo/uso terapêutico , Criança , Feminino , Humanos
2.
Brain Dev ; 26(7): 453-8, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15351081

RESUMO

The long-term effects of the sodium salt of dichloroacetic acid (DCA) were evaluated in four patients with mitochondrial encephalomyelopathy with lactic acidosis and stroke-like episodes (MELAS) carrying A3243G mutation. Oral administration of DCA in MELAS patients was followed for an average of 5 years 4 months. Serum levels of lactate and pyruvate were maintained at around 10 and 0.6 mg/dl, respectively. Serum levels of DCA were 40-136 microg/ml. Symptoms responding to treatment included persistent headache, abdominal pain, muscle weakness, and stroke-like episodes. In contrast, no improvements in mental status, deafness, short stature, or neuroelectrophysiological findings were observed. Adverse effects included mild liver dysfunction in all patients, hypocalcemia in three and peripheral neuropathy in one. None of these adverse events was severe enough to require discontinuation of treatment. To determine suitable indications for DCA therapy, analysis of many more patients who have undergone DCA administration is required.


Assuntos
Ácido Dicloroacético/administração & dosagem , Ácido Dicloroacético/efeitos adversos , Síndrome MELAS/tratamento farmacológico , Síndrome MELAS/fisiopatologia , Dor Abdominal/tratamento farmacológico , Administração Oral , Adolescente , Doença Hepática Induzida por Substâncias e Drogas , Criança , Ácido Dicloroacético/sangue , Feminino , Cefaleia/tratamento farmacológico , Humanos , Hipocalcemia/induzido quimicamente , Ácido Láctico/sangue , Síndrome MELAS/sangue , Mitocôndrias/efeitos dos fármacos , Debilidade Muscular/tratamento farmacológico , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Ácido Pirúvico/sangue , Acidente Vascular Cerebral/tratamento farmacológico , Acidente Vascular Cerebral/prevenção & controle , Fatores de Tempo , Resultado do Tratamento
3.
Brain Dev ; 35(6): 582-5, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22981260

RESUMO

We report the case of a boy with myoclonic epilepsy with ragged-red fibers (MERRF) who had astatic seizures since 2 years of age and later developed ataxia, absence seizures, and myoclonus. Almost homoplasmic A8344G mutation of mitochondrial DNA (m.8344A>G mutation) was detected in lymphocytes. He developed late-onset Leigh syndrome (LS) when he contracted pneumonia at 6 years. He developed bulbar palsy and deep coma. MRI demonstrated lesions in the brainstem, basal ganglia, and cerebral cortex. Three similar cases have been reported; two carried the almost-homoplasmic m.8344A>G mutation in muscle tissue. These suggested that almost homoplastic m.8344A>G mutation developed clinical phenotype of MERRF in the early stage and late-onset Leigh syndrome in the late course of the disease.


Assuntos
Doença de Leigh/complicações , Síndrome MERRF/complicações , Encéfalo/patologia , Criança , DNA Mitocondrial/genética , Eletroencefalografia , Humanos , Doença de Leigh/genética , Doença de Leigh/patologia , Síndrome MERRF/genética , Síndrome MERRF/patologia , Imageamento por Ressonância Magnética , Masculino , Mutação/genética , Polimorfismo de Fragmento de Restrição
4.
Brain Dev ; 32(3): 244-7, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19278800

RESUMO

We report the case of a girl with Tay-Sachs disease who had convulsions and deteriorated rapidly after an upper respiratory infection at the age of 11 months. At the age of 16 months, her seizures became intractable and magnetic resonance imaging of the brain showed high signal intensity on T2-weighted images and marked swelling in the white matter and basal nucelei of the right hemisphere. Her seizures and right hemisphere lesion improved with glycerol and dexamethasone treatment. When dexamethasone was discontinued, her symptoms worsened and lesions later appeared in the left hemisphere. Her cerebrospinal fluid showed elevated levels of the cytokines TNF-alpha and IL-5. It is considered that inflammation contributes to disease progression in Tay-Sachs disease.


Assuntos
Citocinas/metabolismo , Fibras Nervosas Mielinizadas/patologia , Doença de Tay-Sachs/metabolismo , Doença de Tay-Sachs/patologia , Anti-Inflamatórios/uso terapêutico , Pré-Escolar , Dexametasona/uso terapêutico , Feminino , Glicerol/uso terapêutico , Humanos , Imageamento por Ressonância Magnética/métodos , Doença de Tay-Sachs/tratamento farmacológico
6.
Scand J Infect Dis ; 39(11-12): 1067-70, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17852929

RESUMO

We report the case of a 2-y, 11-month-old boy with G1P[8] rotavirus infection accompanied by acute meningoencephalitis. Substitutions in both the VP4 and VP7 genes were found in the identified strain. A commonly circulating G1P[8] rotavirus with such mutations might be associated with the pathogenesis of CNS complications, including meningoencephalitis.


Assuntos
Meningite Viral/virologia , Infecções por Rotavirus/virologia , Rotavirus/classificação , Rotavirus/genética , Aciclovir/uso terapêutico , Antibacterianos/uso terapêutico , Antígenos Virais/genética , Antivirais/uso terapêutico , Povo Asiático , Proteínas do Capsídeo/genética , Carbenicilina/uso terapêutico , Pré-Escolar , Glicerol/uso terapêutico , Humanos , Japão/etnologia , Masculino , Meningite Viral/diagnóstico , Filogenia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA